Status:
COMPLETED
Evaluation of Screening Methods for Treatment of Meibomian Gland Dysfunction
Lead Sponsor:
TearScience, Inc.
Conditions:
Chalazion
Dry Eye Syndromes
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
The objective is to evaluate the feasibility of using additional screening methods to optimize effectiveness outcomes with the LipiFlow System for application of heat and pressure therapy in adult pat...
Eligibility Criteria
Inclusion
- Meibomian gland dysfunction
- Dry Eye symptoms
Exclusion
- Ocular surgery, ocular injury or ocular Herpes infection within past 3 months
- Active ocular infection
- Active ocular inflammation or recurrent inflammation within past 3 months
- Moderate to severe allergic conjunctivitis
- Severe eyelid inflammation
- Eyelid abnormalities that affect lid function
- Ocular surface abnormalities that may compromise corneal integrity
- Systemic disease conditions or medications that cause dry eye
- Use of other treatments for meibomian gland dysfunction or dry eye
- Pregnant or nursing women
- Participation in another ophthalmic clinical trial within past 30 days
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01202747
Start Date
September 1 2010
End Date
January 1 2011
Last Update
December 6 2011
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Hoffman Estates, Illinois, United States
2
Boston, Massachusetts, United States
3
Winchester, Massachusetts, United States